Generic Name: Obeticholic Acid
Brand Name: Ocaliva
Manufacturer: Intercept Pharma Canada, Inc.
Therapeutic Area: Primary Biliary Cholangitis
Indications: Primary biliary cholangitis
Submission Type: Initial
Project Status: Complete
Date Recommendation Issued: July 25, 2017
Recommendation Type: Reimburse with clinical criteria and/or conditions